1 Patent
- US125595632026Müllerian Inhibiting Substance Type 2 Receptor (misiir)-specific CAR T Cells for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies
The Trustees Of The University Of Pennsylvania
0 cites
The Trustees Of The University Of Pennsylvania